SCHEMBL25528646

SCHEMBL25528646

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(Cc3ccncc3)c2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRA P10827 7/20 0.52
THRB P10828 7/20 0.52
LMNA P02545 1/20 0.39
POLB P06746 3/20 0.36
NOD2 Q9HC29 1/20 0.36
SLC7A5 Q01650 1/20 0.36
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35
CYP3A4 P08684 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23003819 0.90 THRB (0.61) THRATHRBLMNA
SCHEMBL25528657 0.90 THRA (0.55) THRATHRBLMNASLC7A5ALDH1A1
SCHEMBL23003698 0.89 THRA (0.50) THRATHRBLMNAPOLBNOD2
SCHEMBL25528726 0.89 THRA (0.56) THRATHRBSLC7A5CYP3A4
SCHEMBL25528658 0.89 THRB (0.54) THRATHRBSLC7A5CYP3A4
SCHEMBL25528661 0.88 THRB (0.51) THRATHRBSLC7A5
SCHEMBL25528612 0.88 THRA (0.53) THRATHRBLMNASLC7A5ALDH1A1
SCHEMBL25528664 0.85 THRB (0.50) THRATHRBSLC7A5CYP3A4
SCHEMBL25528638 0.85 THRA (0.50) THRATHRBPOLBSLC7A5ALDH1A1
SCHEMBL25528689 0.83 THRB (0.50) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885LMNA 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.